RxDoctor Payments Data

Tamberly McCoy

Family Medicine · Owensboro, KYNPI 1386739464

Payments from drug & device makers

$8,448in general payments, 2019–2025

Across 620 payments — averaging $13.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • Lilly USA, LLC$785
  • Amarin Pharma, Inc.$577
  • Pfizer$402
  • Otsuka America Pharmaceutical, Inc.$400
  • plus $4K from 52 others

What the payments were for

  • Food & beverage$8,07196%
  • Education$3584%
  • Gifts$180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk98$1,228
AbbVie(2 entities)94$1,107
Lilly USA, LLC58$785
Amarin Pharma, Inc.67$577
Pfizer27$402
Otsuka America Pharmaceutical, Inc.25$400
Astellas Pharma US Inc16$297
Lundbeck LLC17$266
Merck19$253
Sunovion Pharmaceuticals Inc.15$213
Exact Sciences13$211
AstraZeneca15$198
Amgen(2 entities)12$196
Sanofi-aventis U.S. LLC14$195
Boehringer Ingelheim11$157
GSK9$146
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$126
Supernus Pharmaceuticals, Inc.7$110
Eisai Inc.8$104
Biohaven Pharmaceutical Holding Company Ltd.5$98
Sumitomo Pharma America, Inc.5$90
Avanir Pharmaceuticals, Inc.6$84
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$72
Almatica Pharma LLC3$68
Phathom Pharmaceuticals, Inc.5$66
Biogen3$64
Abbott4$61
Aimmune Therapeutics, Inc.4$58
Neurocrine Biosciences, Inc.3$58
Idorsia Pharmaceuticals US Inc3$53
Novartis3$45
Nestle Healthcare Nutrition Inc.3$45
Corcept Therapeutics2$39
E.r. Squibb & Sons, L.L.C.2$38
Insulet Corporation2$38
Takeda Pharmaceuticals U.S.A., Inc.2$37
Bayer2$36
Esperion Therapeutics, Inc.2$34
Covis Pharma GmbH2$32
Bausch Health US, LLC2$30
Organogenesis Inc.1$30
Kowa Pharmaceuticals America, Inc.2$29
Vanda Pharmaceuticals Inc.1$21
Xeris Pharmaceuticals, Inc.1$19
Axsome Therapeutics, Inc.1$19
Ortho Dermatologics, A Division Of Bausch Health US, LLC1$18
Azurity Pharmaceuticals, Inc.1$18
Ascend Therapeutics US, LLC1$18
Zealand Pharma US, Inc.1$17
Acadia Pharmaceuticals Inc1$17
Teva Pharmaceuticals USA, Inc.1$17
Shire North American Group Inc1$17
Johnson & Johnson1$16
Nevro Corp.1$16
Biohaven Pharmaceuticals, Inc.1$15
Sanofi Pasteur Inc.1$15
Tris Pharma Inc1$14
Currax Pharmaceuticals LLC1$14

How this compares

$8,448 in reported general payments places this provider in the 90th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$215,922
Medicare patients
557
Services billed
6,198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide225$237,245
EliquisApixaban364$168,656
TrulicityDulaglutide62$72,115
JardianceEmpagliflozin120$71,110
JanuviaSitagliptin Phosphate125$68,875
FarxigaDapagliflozin Propanediol73$53,837
RexultiBrexpiprazole43$53,365
JanumetSitagliptin Phos/Metformin Hcl38$50,771
XifaxanRifaximin46$50,582
NuedextaDextromethorphan Hbr/Quinidine38$37,870
Tresiba Flextouch U-200Insulin Degludec33$37,331
MounjaroTirzepatide33$33,577
Janumet XrSitagliptin Phos/Metformin Hcl32$32,031
XareltoRivaroxaban58$27,127
ArexvyRsvpref3 Antigen/As01e/Pf78$23,786

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,228$255,407240 claims
PfizerEliquis, Premarin$402$183,377397 claims
MerckJanuvia, Janumet, Janumet Xr$253$151,678195 claims
Lilly USA, LLCTrulicity, Mounjaro$785$105,69295 claims
Boehringer IngelheimJardiance, Tradjenta$157$81,833140 claims
AbbVieVraylar, Linzess, Namzaric$1,107$55,52167 claims
AstraZenecaFarxiga$198$53,83773 claims
Otsuka America Pharmaceutical, Inc.Rexulti$400$53,36543 claims
GSKArexvy, Trelegy Ellipta, Incruse Ellipta$146$50,926133 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$72$50,58246 claims
Avanir Pharmaceuticals, Inc.Nuedexta$84$37,87038 claims
Johnson & JohnsonXarelto$16$27,12758 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Owensboro

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →